What You Need to Know Ahead of Becton, Dickinson and Company's Earnings Release

Franklin Lakes, New Jersey-based Becton, Dickinson and Company (BDX) develops, manufactures, and sells medical supplies, devices, and interventional products for healthcare institutions, physicians, and the general public. Valued at a market cap of $45.1 billion, the company is scheduled to announce its fiscal Q2 earnings for 2026 before the market opens on Thursday, May 7. 

Before this event, analysts expect this healthcare company to report a profit of $2.77 per share, down 17.3% from $3.35 per share in the year-ago quarter. The company has topped Wall Street’s bottom-line estimates in each of the last four quarters. Its earnings of $2.91 per share in the previous quarter outpaced the forecasted figure by 3.2%.